Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, May 17, 2012

Statin Benefits Remain Even in Low-Risk Cases

You'll have to consult your doctor on this. I only have 41 posts for your preparation for that meeting.
http://www.medpagetoday.com/Cardiology/Prevention/32739
A large meta-analysis suggests that statins provide substantial benefit for primary prevention, prompting researchers to question current guidelines.
For individuals without a history of cardiovascular disease, statins reduced the risk of vascular and all-cause mortality by 15% and 9%, respectively, for every 1 mmol/L reduction in low-density lipoprotein (LDL) cholesterol, according to Borislava Mihaylova, MSc DPhil, and colleagues on the Cholesterol Treatment Trialists' (CTT) Collaborators writing team.
Overall, in the five baseline risk groups, there was a 21% reduction in the relative risk of major vascular events and all-cause death, irrespective of age, baseline LDL, or previous cardiovascular disease for every 1 mmol/L reduction in LDL cholesterol (P<0.001), they reported online in The Lancet.
In addition, each 5-year risk group separately had significant reductions in major vascular events.

The rest at the link.

No comments:

Post a Comment